CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Purple Biotech Ltd   (PPBT)
Other Ticker:  
 

Purple Biotech Ltd 's Quick Ratio

PPBT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




PPBT Quick Ratio (Dec 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Current Liabilities Change 66.07 % 66.07 % 66.07 % 66.07 % 37.19 %
Y / Y Cash & cash equivalent Change 38.02 % 38.02 % 38.02 % 38.02 % -3.17 %
Quick Ratio MRQ 2.13 2.13 2.13 2.13 2.56
Overall Ranking # 1442 # 1591 # 1747 # 1874 # 1697
Seq. Current Liabilities Change 0 % 0 % 0 % 66.07 % 0 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % 38.02 % 0 %

New: More PPBT's historic Quick Ratios >>


Comment on PPBT Quick Ratio in the forth quarter 2022
Regardless of the sequential decrease in Current Liabilities, during the forth quarter 2022, Quick Ratio deteriorated to 2.13 below Purple Biotech Ltd 's average Quick Ratio.

Within Major Pharmaceutical Preparations industry 367 other companies have achieved higher Quick Ratio than Purple Biotech Ltd in forth quarter 2022. While total ranking remained the same in the IV Quarter 2022 compared to the third quarter 2022 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents PPBT´s has?
What are PPBT´s Current Liabilities?
Quick Ratio forth quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 368
Healthcare Sector # 654
Overall Market # 1439


Quick Ratio Statistics
High Average Low
3.63 2.39 1.24
(Dec 31 2020)   (Dec 31 2019)




Financial Statements
Purple Biotech Ltd 's Current Liabilities $ 7 Millions Visit PPBT's Balance sheet
Purple Biotech Ltd 's Cash & cash equivalent $ 15 Millions Visit PPBT's Balance sheet
Source of PPBT's Sales Visit PPBT's Sales by Geography


Cumulative Purple Biotech Ltd 's Quick Ratio

PPBT's Quick Ratio for the trailling 12 Months

PPBT Quick Ratio

 (Dec 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Current Liabilities TTM Growth 66.07 % 66.07 % 66.07 % 66.07 % 37.19 %
Y / Y Cash & cash equivalent TTM Growth 38.02 % 38.02 % 38.02 % 38.02 % -3.17 %
Quick Ratio TTM 2.13 2.2 2.29 2.41 2.56
Total Ranking TTM # 464 # 4232 # 0 # 0 # 1447
Seq. Current Liabilities TTM Growth 0 % 0 % 0 % 66.07 % 0 %
Seq. Cash & cash equivalent TTM Growth 0 % 0 % 0 % 38.02 % 0 %

Quick ratio ranking by company, industry and sector >> Back to PPBT Financial Strength Comparisons >> Go to Compare PPBT Quick Ratio to its Competitors

TTM Quick Ratio Comment
On the trailing twelve months basis Due to unchange in Current Liabilities in the IV Quarter 2022 to $7.06 millions, cumulative Quick Ratio decreased to 2.13 below the Purple Biotech Ltd average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 129 other companies have achieved higher Quick Ratio than Purple Biotech Ltd . While Quick Ratio overall ranking has improved so far to 464, from total ranking during the twelve months ending third quarter 2022 at 4232.

Explain Quick Ratio?
How much Cash & cash equivalents PPBT´s has?
What are PPBT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 130
Healthcare Sector # 239
Within the Market # 464


TTM Quick Ratio Statistics
High Average Low
3.63 2.15 1.19
(Dec 31 2020)   (Jun 30 2019)




Companies with similar Quick Ratio in the quarter ending Dec 31 2022, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2022 MRQ Cash & cash equivalentDec 31 2022 MRQ Current Liabilities
Renovorx Inc   5.84 $ 6.440  Millions$ 1.102  Millions
Vistagen Therapeutics Inc   5.84 $ 25.037  Millions$ 4.287  Millions
Geovax Labs Inc   5.82 $ 27.613  Millions$ 4.748  Millions
Bellicum Pharmaceuticals Inc   5.79 $ 21.837  Millions$ 3.772  Millions
Vincerx Pharma Inc   5.73 $ 52.459  Millions$ 9.156  Millions
Hillstream Biopharma Inc   5.69 $ 6.511  Millions$ 1.145  Millions
Ngm Biopharmaceuticals Inc   5.67 $ 271.492  Millions$ 47.842  Millions
Pyxis Oncology Inc   5.67 $ 179.293  Millions$ 31.634  Millions
Assembly Biosciences Inc   5.62 $ 91.610  Millions$ 16.296  Millions
Atreca inc   5.53 $ 70.495  Millions$ 12.749  Millions
Zynerba Pharmaceuticals Inc   5.52 $ 50.641  Millions$ 9.173  Millions
Affimed N v   5.49 $ 213.120  Millions$ 38.809  Millions
Galecto Inc   5.42 $ 60.224  Millions$ 11.107  Millions
Werewolf Therapeutics Inc   5.39 $ 129.315  Millions$ 23.989  Millions
Carisma Therapeutics inc   5.39 $ 166.919  Millions$ 30.984  Millions
Selecta Biosciences Inc  5.37 $ 134.602  Millions$ 25.077  Millions
Tempest Therapeutics Inc   5.33 $ 31.230  Millions$ 5.864  Millions
Mei Pharma Inc   5.31 $ 113.256  Millions$ 21.310  Millions
Reviva Pharmaceuticals Holdings Inc   5.26 $ 18.520  Millions$ 3.520  Millions
Gain Therapeutics inc  5.24 $ 20.139  Millions$ 3.841  Millions
Exicure Inc   5.23 $ 8.577  Millions$ 1.639  Millions
Arcus Biosciences Inc   5.23 $ 1,009.000  Millions$ 193.000  Millions
Gossamer Bio Inc   5.19 $ 255.678  Millions$ 49.230  Millions
Catalyst Pharmaceuticals Inc   5.18 $ 298.395  Millions$ 57.588  Millions
Biohaven Ltd   5.17 $ 465.341  Millions$ 90.021  Millions
Blueprint Medicines Corporation  5.16 $ 944.992  Millions$ 183.234  Millions
Zymeworks Inc   5.15 $ 492.232  Millions$ 95.625  Millions
Eyenovia inc   5.09 $ 22.983  Millions$ 4.512  Millions
Beyondspring Inc   5.07 $ 37.268  Millions$ 7.352  Millions
Connect Biopharma Holdings Limited  5.06 $ 79.010  Millions$ 15.624  Millions

Date modified: 2023-03-23T13:12:32+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071